One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often leads to treatment failure. When we say the body "resists" cancer ...

A new approach that used CRISPR to engineer adipocytes and implant them in mice models of cancer reduced cancer progression.